• Recent advancements in lipid-mRNA nanoparticles as a treatment option for cancer immunotherapy

• (Karmacharya Prajeena) (Patil Basavaraj Rudragouda) ±èÁ¾¿À(Kim Jong-Oh)

• Journal of Pharmaceutical Investigation  2022³â 52±Ç 4È£ 415~426

• Ç׾ϸ鿪ġ·á ÈÄ ¹ß»ýÇÑ ¿ÜÀü½Å°æ¸¶ºñ Çѹæ Ä¡Çè 1·Ê

• A Case Report of Abducens Nerve Palsy after Cancer Immunotherapy Treated with Korean Medicine

• ±èÀçÈ£(Kim Jae-Ho) °íÇý¿¬(Ko Hye-Yeon) ±è¹ÎÈñ(Kim Min-Hee)

• Çѹæ¾ÈÀ̺ñÀÎÈÄÇǺΰúÇÐȸÁö  2022³â 35±Ç 3È£ 114~122

• ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È°ú ¾Ï ¸é¿ª Ä¡·á

• Microbiome and Cancer Immunotherapy

• È«¹®±â(Hong Moon-Ki) Á¤¹Î±Ô(Jung Min-Kyu)

• ´ëÇѳ»°úÇÐȸÁö  2021³â 96±Ç 4È£ 312~317

• Natural killer cells as a promising therapeutic target for cancer immunotherapy

• ±è³ª¿µ(Kim Na-Young) ÀÌÇöÈ£(Lee Hyeon-Ho) ÀÌÈ¿Á¤(Lee Hyo-Jung) ÃÖ¿ì¼±(Choi Woo-Seon) ÀÌÁøÁÖ(Lee Jin-Ju) ±èÇå½Ä(Kim Hun-Sik)

• Archives of Pharmacal Research  2019³â 42±Ç 7È£ 591~606

• Transendothelial migration (TEM) of in vitro generated dendritic cell vaccine in cancer immunotherapy

• (Ashraf Muhammad Umer) (Jeong Yi-Deul) (Roh Seung-Eon) ¹è¿ë¼ö(Bae Yong-Soo)

• Archives of Pharmacal Research  2019³â 42±Ç 7È£ 582~590

• Roles of NKT cells in cancer immunotherapy

• ¹èÀº¾Æ(Bae Eun-Ah) ¼­Çü¼®(Seo Hyung-Seok) ±èÀϱÔ(Kim Il-Kyu) (Jeon In-Su) °­Ã¢¿­(Kang Chang-Yuil)

• Archives of Pharmacal Research  2019³â 42±Ç 7È£ 543~548

• Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

• ÃÖÀ±½Ä(Choi Yun-Sik) ÀÌ»óÇõ(Lee Sang-Hyuk) (Kim Kap-Youl) ±è¼öÇö(Kim Soo-Hyun) Á¤¿¬ÁØ(Chung Yeun-Jun) (Lee Charles)

• Experimental & Molecular Medicine  2018³â 50±Ç 8È£ 99~99

• Nano delivery systems and cancer immunotherapy

• (Le Quoc-Viet) (Choi Jin-Joo) ¿ÀÀ¯°æ(Oh Yu-Kyoung)

• Journal of Pharmaceutical Investigation  2018³â 48±Ç 5È£ 527~539

• Identificaiton of Novel Immunogenic Human Papillomavirus Type 16 E7-Specific Epitopes Restricted to HLA-A*33;03 for Cervical Cancer Immunotherapy

• ±è¼ºÈÆ(Kim Sung-Hoon) Á¤Çý¿ø(Chung Hye-Won) °øÈÆ¿µ(Kong Hoon-Young) ÀÓÁ¾¹é(Lim Jong-Baeck)

• Yonsei Medical Journal  2017³â 58±Ç 1È£ 43~50

• Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy

• ±ÇÇüÁØ(Kwon Hyung-Joon) ±è³ª¿µ(Kim Na-Young) ±èÇå½Ä(Kim Hun-Sik)

• Experimental & Molecular Medicine  2017³â 49±Ç 3È£ 4~4

• Recent studies on micro-/nano-sized biomaterials for cancer immunotherapy

• ¹Ú¿Á(Park Ok) (Yu Gyeong-Hui) Á¤ÈñÁ¤(Jung Hee-Jung) ¸ñÇýÁ¤(Mok Hye-Jung)

• ¾àÁ¦ÇÐȸÁö  2017³â 47±Ç 1È£ 11~18

• Cancer Immunotherapy: Cancer Vaccines

• À̳ª°æ(Lee Na-Kyung) ±èÈ«¼º(Kim Hong-Sung)

• ´ëÇÑÀÇ»ý¸í°úÇÐȸÁö  2017³â 23±Ç 3È£ 161~165

• ¾Ï ¸é¿ª Ä¡·áÀÇ ÃֽŠÁö°ß

• Recent Updates in Cancer Immunotherapy

• Á¤¸¸±â(Chung Man-Ki) ±èº¸¿µ(Kim Bo-Young)

• ´ëÇÑÀ̺ñÀÎÈÄ-µÎ°æºÎ¿Ü°úÇÐȸÁö  2015³â 58±Ç 7È£ 449~455

• Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic

• (Hoang My-Dung) Á¤¼ºÈÆ(Jung Sung-Hoon) ÀÌÇöÁÖ(Lee Hyun-Ju) ÀÌÀ±°æ(Lee Youn-Kyung) (Thanh-Nhan Nguyen-Pham) (Choi Nu-Ri) (Manh-Cuong Vo) À̽½Å(Lee Seung-Shin) ¾ÈÀç¼÷(Ahn Jae-Sook) ¾ç´öȯ(Yang Deok-Hwan) ±è¿©°æ(Kim Yeo-Kyeoung) ±èÇüÁØ(Kim Hyeoung-Joon) ÀÌÁ¦Áß(Lee Je-Jung)

• Chonnam Medical Journal  2015³â 51±Ç 1È£ 1~7

• Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease

• ÀÓ¿ëÅÃ(Lim Yong-Taik)

• Clinical and Experimental Vaccine Research  2015³â 4±Ç 1È£ 54~58

• Á¾¾ç¸é¿ªÄ¡·á: Áß¼¼ ¾ÏÈæ½Ã´ë¿¡¼­ ¸£³×»ó½º½Ã´ë·Î

• Cancer Immunotherapy: The Dawn of the Renaissance after the Medieval Dark Ages

• ÀÌ´ëÈ£(Lee Dae-Ho)

• ´ëÇѳ»°úÇÐȸÁö  2014³â 87±Ç 3È£ 284~295

• Way to go to exploit NK cellsE versatile talents for cancer immunotherapy

• Á¶´ö(Cho Duck)

• ´ëÇÑÇ÷¾×ÇÐȸÁö  2014³â 49±Ç 3È£ 139~140

• The CD28-B7 Family in Anti-Tumor Immunity: Emerging Concepts in Cancer Immunotherapy

• (Leung Joanne) ¼­¿õ°æ(Suh Woong-Kyung)

• Immune Network  2014³â 14±Ç 6È£ 265~276

• ÀÚ¿¬»ìÇؼ¼Æ÷¿Í Ç׾ϸ鿪ġ·á

• Natural Killer Cell and Cancer Immunotherapy

• ±èÇå½Ä(Kim Hun-Sik)

• Hanyang Medical Reviews  2013³â 33±Ç 1È£ 59~64

• Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy

• ¹Ú¿µ¹Î(Park Yeong-Min) À̽ÂÁØ(Lee Seung-Jun) ±è¿µ¼·(Kim Young-Seob) À̹®Èñ(Lee Moon-Hee) Â÷±æ¼±(Cha Gil-Sun) Á¤Àδö(Jung In-Duk) °­ÅÂÈï(Kang Tae-Heung) ÇÑÈñµ¿(Han Hee-Dong)

• Immune Network  2013³â 13±Ç 5È£ 177~183

• Çѹæ Á¾¾ç¸é¿ªÄ¡·á¸¦ ÅëÇÑ ÀüÀÌÀç¹ß ¾ïÁ¦ ¹æ¹ý·Ð ¿¬±¸

• A Review of the Literature of the Promising Methodology of Cancer Immunotherapy Involving the Use of Traditional Oriental Herbal Medicine for Inhibiting Metastasis and Recurrence

• ÀÌÈ¿Àç(Lee Hyo-jae) ÀÌ¿¬¿ù(Lee Yeon-Weol) À¯È­½Â(Yoo Hwa-Seung) Á¶Á¾°ü(Cho Chong-Kwan)

• ´ëÇѾÏÇÑÀÇÇÐȸÁö  2010³â 15±Ç 1È£ 89~103

• Induction of 90K-specific Cytotoxic T Lymphocytes for Colon Cancer Immunotherapy

• ÀÌÁöÈñ(Lee Ji-Hee) ¹Ú¸í¼÷(Park Myung-Suk) Á¤ÀÍÁÖ(Chung Ik-Joo)

• Immune Network  2010³â 10±Ç 6È£ 206~211

• Expansion and Activation of Natural Killer Cells for Cancer Immunotherapy

• Á¶´ö(Cho Duck) (Campana Dario)

• ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸÁö  2009³â 29±Ç 2È£ 89~96

• MUC1 from the Mucin Family as Potential Tools in Breast Cancer Immunotherapy

• ¹ÚÈï±Ô(Park Heung-Kyu) (Seo U-Hyoung)

• Journal of Breast Cancer  2009³â 12±Ç 3È£ 125~133

• Ç׿øÁ¦½Ã¼¼Æ÷¸¦ ÀÌ¿ëÇÑ ¾Ï Ä¡·áÁ¦ °³¹ßÀü¸Á

• The Prospective of Antigen-presenting Cells in Cancer Immunotherapy

• ½ÉµÎÈñ(Sim Doo-Hee) ÀÌÀçÈ­(Lee Jae-Hwa)

• Çѱ¹»ý¹°°øÇÐȸÁö  2004³â 19±Ç 6È£ 415~420

• ¼öÁö»ó¼¼Æ÷¸¦ ÀÌ¿ëÇÑ Ç×¾Ï ¸é¿ª Ä¡·á: »ýÁã ½ÅÀå¾Ï ¸ðµ¨À» ÀÌ¿ëÇÑ ¿¬±¸

• Dendritic Cell Based Cancer Immunotherapy: in vivo Study with Mouse Renal Cell Carcinoma Model

• ÀÌÇö¾Æ/Lee HA ÃÖ±¤¹Î/¹é¼Ò¿µ/ÀÌÈ«±â/Á¤Ã¶¿ø/Choi KM/Baek SY/Lee HG/Jung CW

• Immune Network  2004³â 4±Ç 1È£ 44~52

• ¼öÁö»ó ¼¼Æ÷¸¦ ÀÌ¿ëÇÑ Á¾¾ç ¸é¿ª¿ä¹ý

• Dendritic Cell-Based Cancer Immunotherapy

• ¹ÚÇöÁø

• ¼Ò¾Æ°ú  2003³â 46±Ç 10È£ 947~951

• äßÀÇ Øóæ¹èþÛö

• Cancer Immunotherapy

• ±èµ¿Áý(Kim Dong-Jip)

• ´ëÇѳ»°úÇÐȸÁö  1977³â 20±Ç 6È£ 474~480